Navigation Links
Experimental antibody shows early promise for treatment of childhood tumor
Date:5/8/2014

doses of hu14.18K322A. The immunotherapy is designed to activate the disease-fighting immune system to attack and kill tumor cells. Every 28 days, patients received an infusion of hu14.18K322A once daily for four days.

Of the 31 patients evaluated after two or more rounds of treatment, the disease stabilized in nine patients, tumors shrank in two patients and were undetectable in four more, researchers reported. "Four patients are alive after more than two-and-a-half years without additional therapy," Navid said.

Hu14.18K322A is an antibody engineered to recognize and attach to a molecule called the GD2 antigen. GD2 is found on the surface of almost all neuroblastoma cells as well as other tumors, including the skin cancer melanoma, the bone cancer osteosarcoma and soft-tissue sarcomas. The antigen is found on the normal cells of just a few tissues.

The antibody is produced in the Children's GMP, LLC. Navid said the study would not have been possible without the GMP, an on-site facility that makes highly specialized medicines and other biologics under government-approved Good Manufacturing Practices regulations.

The monoclonal antibody in this study is one of several antibodies targeting GD2 that are in clinical development for treatment of neuroblastoma. Hu14.18K322A is a modified version of another antibody. The main change, a point mutation in the human gene for hu14.18, was designed to address treatment-limiting pain by generating a more tailored response that avoided triggering part of the immune response called the complement cascade. In addition, the hu14.18K322A has fewer mouse components, making it less likely the body will reject the antibody. It is also made in a cell line that may improve its ability to kill tumor cells.

In this study, pain remained the most common side effect associated with hu14.18K322A treatment. While 68 percent of patients reported severe pain during the first round of treatment, Navid
'/>"/>

Contact: Summer Freeman
summer.freeman@stjude.org
901-595-3061
St. Jude Children's Research Hospital
Source:Eurekalert

Page: 1 2 3

Related medicine news :

1. Experimental drug prolongs life span in mice
2. Experimental drug shows promise for treatment-resistant leukemias
3. Diabetes drug shows promise in reducing Alzheimers disease in an experimental model
4. Experimental drug could enhance multiple myeloma and myeloid leukemia therapies
5. Experimental drug shows encouraging results in treating most common form of lung cancer
6. Studies of experimental hepatitis C drug show promise for preventing recurrence in liver transplant
7. ASSURE study of experimental agent to raise HDL yields disappointing and surprising results
8. York physicists offer novel insight into experimental cancer treatment
9. Experimental Drug Shows Benefits Against Melanoma in Early Study
10. Experimental Drugs Show Promise Against Prostate Cancer
11. Experimental Drug Seems to Aid Memory in Mice With Alzheimers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... 22, 2015 Wimbledon Health Partners, the ... (EKG), echocardiogram and NCV testing , is proud ... respected All American National athlete, to the Wimbledon Athletics ... the high level of testing and information it provides ... their athletic trainers, this way they can focus on ...
(Date:5/22/2015)... AZ (PRWEB) May 22, 2015 In ... Olympics, Parker and Sons is offering to donate $5 ... installing an AC unit or water softening system. Customers ... behalf; Parker and Sons gets business; and the Special ... , The Special Olympics helps over 4.4 million athletes, ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Co founders Greenlee ... is to allow general dentists to immediately deliver fully integrated ... based on that of the medical surgeon. , The ... main roadblocks preventing general dentists from placing dental implants. ... necessary steps to introduce the surgical placement of dental implants ...
(Date:5/22/2015)... Puritan Medical Products, a Maine ... diagnostic, environmental, and forensics industries celebrates 96 years ... the US. At a time when countless manufacturing ... Puritan remains committed to designing and manufacturing their ... facility. , Since 1919, Puritan has focused on ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 Javon ... to be recognized for providing the highest quality emergency ... of health care decision-making,” said Javon R. Bea, President ... the commitment of our employee/partners to care for and ... , Hospitals do not apply for this award, but ...
Breaking Medicine News(10 mins):Health News:Wimbledon Athletics Recruits Team USA Athlete 2Health News:Wimbledon Athletics Recruits Team USA Athlete 3Health News:Parker and Sons is Proud to Support the Special Olympics with Their Everybody Wins Program 2Health News:First of Its Kind Dental Implant Training and Surgicenter to Open in June 2Health News:Maine Swab Company Celebrates 96 Years of American-made Products 2Health News:Mercy Hospital and Trauma Center Receives Women’s Choice Award for Emergency Care - Mercy Health System Javon Bea 2
... finds , , FRIDAY, Oct. 31 (HealthDay News) -- The more weight ... have a large baby, posing health risks to both mother and ... than 40 pounds -- the maximum recommended pregnancy weight gain -- ... 9 pounds, the researchers said. , An estimated one-fifth of women ...
... amino acid glycine has been shown to be anti-inflammatory ... dietary glycine protected both the lung and liver against ... and improved graft survival after liver transplantation. The influence ... was not known. , A research article to be ...
... TACE has been widely accepted as a choice of ... and reproducible technique for assessing perfusion changes due to ... few reports on the application of this technique in ... of perfusion parameters. , A research article published on ...
... to sign up online at http://www.diabetesatlanta.org , ATLANTA, ... than 600,000 Georgians, could be present in more than,300,000 more, ... disease?, No. The answer is diabetes., And, new ... the U.S. has,nearly doubled in the past 10 years - ...
... organ donation - where people have to opt out of donating ... tackle a growing waiting list for transplant. , That is the ... the illegal trade of body parts, who has recently joined the ... more than 7,500 patients in the UK currently on the waiting ...
... InStil Health,Insurance Co., a leading provider of Medicare ... South Carolina and Georgia, announced today,that longtime insurance ... operating officer of the company., Hart has ... insurance industry,and extensive knowledge of the Medicare program. ...
Cached Medicine News:Health News:Excess Weight Gain During Pregnancy a Risk to Mother and Child 2Health News:As Diabetes Reaches Epidemic Levels in Georgia and U.S., Thousands Drawn to Diabetes University in Atlanta Nov. 8 2Health News:'Opt out' system could solve donor organ shortage, says researcher 2Health News:Jim Hart Named President, COO of InStil Health Insurance Co. 2
(Date:5/22/2015)... May 22, 2015  Effective staffing of key ... recognition and success. Research and ... to provide pharmaceutical and biotech marketing managers with ... budget) that are being channeled into marketing operations ... managers can utilize this report to benchmark their ...
(Date:5/22/2015)... The Assistance Fund announces the addition of ... assistance for copay to individuals diagnosed with Melanoma. ... of the Melanoma Copay Assistance Program to our portfolio ... director. "With each additional program we are closer to ... no one is denied access to medications due to ...
(Date:5/22/2015)... May 22, 2015 The leading companies ... billion global cardiac rhythm management device market dominate ... that Medtronic, St. Jude Medical, Boston Scientific and ... this market segment. The healthcare market research publisher,s ... uses 2015 as a base year, providing forecasts ...
Breaking Medicine Technology:Effective Marketing Services Group Critical for Pharmaceutical Brand Recognition 2The Assistance Fund Adds Melanoma Assistance Program 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 3Kalorama: Top Companies Dominate Cardiac Defibrillator Market 4
... Healthcare Products Association (CHPA) today released the following statement ... law a bill that requires the state to track ... time allowing retailers and pharmacists to block sales to ... "Both the executive and legislative branches in Indiana deserve ...
... May 13, 2011  The following was released today ... Fast Facts ... marketed as dietary supplements that also claim to be ... are falsely promoted with claims to treat illnesses such ...
Cached Medicine Technology:FDA: Don't Buy Drugs Marketed as Antimicrobial Dietary Supplements 2FDA: Don't Buy Drugs Marketed as Antimicrobial Dietary Supplements 3FDA: Don't Buy Drugs Marketed as Antimicrobial Dietary Supplements 4
The Astigmatome makes precise and accurate cuts for astigmatism correction simply and safely. The procedure can be done in the office under topical anesthesia. Complete Set Includes Vacuum Speculum, ...
... of temporary sensing and pacing leads. Our ... temporary pacing leads and improved upon the ... and less traumatic to heart tissue. , ... to provide consistent temporary sensing and pacing ...
... indication for this technique is acquired ... Indications for tricuspid repair are based ... as diagnosed by angiography and dye ... In patients with an irreversible tricuspid ...
... Pro Medical Billing proudly offers distinct ... your area of expertise. ... diagnosis codes and medical records templates ... practice, ob/gyn, sports medicine, ophthalmology, allergy, ...
Medicine Products: